# OnCo record conko-007 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/conko-007/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "conko-007", "NCT01827553" ;
  schema:name "CONKO-007"@en ;
  schema:alternateName "CONKO 007"@en ;
  schema:description "CONKO-007 is the largest test of radiotherapy after chemotherapy for pancreatic cancer that cannot be removed at diagnosis: chemoradiotherapy did not raise the share of all patients reaching a clear-margin operation (25 against 18 percent) or lengthen survival, but among those operated the margins were clear more often (69 against 50 percent)."@en ;
  schema:url <https://onco.cc/trials/conko-007/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT01827553>, <https://doi.org/10.1200/JCO-24-01502> ;
  onco:status "mixed" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/locally-advanced-pdac/> ;
  onco:technologies <https://onco.cc/terms/chemoradiation/>, <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:drugs <https://onco.cc/drugs/folfirinox/>, <https://onco.cc/drugs/gemcitabine/> ;
  onco:terms <https://onco.cc/terms/chemoradiation/>, <https://onco.cc/terms/resection-margins/>, <https://onco.cc/terms/resectability/>, <https://onco.cc/terms/pancreatic-failed-programmes/> .